Virios Therapeutics Inc (NQ: VIRI )
0.1940
+0.0140
(+7.78%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 30, 2024
Add to My Watchlist
Press Releases about Virios Therapeutics Inc
![](https://www.marketbeat.com/logos/articles/med_20230425102535_virios-therapeutics-up-75-on-fibromyalgia-phase-3.jpg)
![](https://mms.businesswire.com/media/20221129005166/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20221114005171/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20221103005169/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20220922005710/en/1096317/4/Virios_Logo_Blue.jpg)
Virios Therapeutics, Inc. Announces Closing of Public Offering
September 22, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220919005894/en/1096317/4/Virios_Logo_Blue.jpg)
Virios Therapeutics, Inc. Announces Pricing of Public Offering
September 19, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220919005764/en/1096317/4/Virios_Logo_Blue.jpg)
Virios Therapeutics, Inc. Announces Proposed Public Offering
September 19, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220919005288/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20220815005047/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20220811005052/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20220810005722/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://www.acnnewswire.com/topimg/Thumb_ViriosTherapeutics2022809.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://mms.businesswire.com/media/20220804005097/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://mms.businesswire.com/media/20220601005293/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20220512005072/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20220505005258/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20220428005155/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20220317005051/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20220228005060/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/13455.jpg?v=0)
RedChip Partners with Benzinga to Host Exclusive Small-Cap CEO Interview Series on January 28
January 26, 2022
From RedChip
Via AccessWire
![](https://mms.businesswire.com/media/20220104005698/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20211201005069/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20211111005226/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20211104005091/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20210908005139/en/1096317/4/Virios_Logo_Blue.jpg)
Virios Therapeutics Granted New Patent for Antiviral Inhibitor Combination
September 08, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20210902005063/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20210819005057/en/1096317/4/Virios_Logo_Blue.jpg)
Virios Therapeutics Announces New Social Media Profiles
August 19, 2021
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.